发明名称 |
METHOD TO INCREASE CLASS I PRESENTATION OF EXOGENOUS ANTIGEN BY HUMAN DENDRITIC CELL |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide methods and compositions for use of human dendritic cells to activate T cells for immunotherapeutic responses against primary and metastatic cancer. <P>SOLUTION: In one embodiment, human dendritic cells exposed to a tumor associated antigen, or an antigenic fragment thereof in combination with bacillus Calmette-Guerin (BCG), are administered to a cancer patient to activate a predominantly CD8<SP POS="POST">+</SP>T cell response in vivo. In an alternate embodiment, human dendritic cells are exposed to a tumor associated antigen or a specific antigenic peptide in combination with BCG in vitro and incubated or cultured with primed or unprimed T cells to activate a predominantly CD8<SP POS="POST">+</SP>T cell response in vitro. The activated T cells are then administered to a cancer patient. Antigen in combination with BCG is processed by dendritic cells through the MHC-CLASS I compartment which provides for a predominantly CD8<SP POS="POST">+</SP>T cell response. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2011225628(A) |
申请公布日期 |
2011.11.10 |
申请号 |
JP20110178147 |
申请日期 |
2011.08.16 |
申请人 |
NORTHWEST BIOTHERAPEUTICS INC |
发明人 |
SALGALLER MICHAEL L;BOYNTON ALTON L |
分类号 |
A61K39/00;C12N5/06;A61K35/12;A61K35/14;A61K35/24;A61K35/26;A61K35/28;A61K35/36;A61K35/50;A61P35/00;A61P35/04;A61P37/04;C12N5/00;C12N5/0784 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|